233 results

• Study Finds Racial Disparity in Which Patients Receive Advanced Pulmonary Embolism Treatment

  December 14, 2022

  Martha Garcia

  A new study warns that people of color are less likely to get advanced, potentially life-saving treatment for pulmonary embolism.

• Study Questions Whether Side Effects of Xeljanz, Similar Drugs, Increase Blood Clot Risks

  September 8, 2022

  Irvin Jackson

  A new study raises doubts about whether Xeljanz and similar drugs increase the risk of blood clots.

• Xeljanz Lawsuit Filed Over Failure to Warn About Risk of Blood Clots, Pulmonary Embolisms

  February 24, 2022

  Irvin Jackson

  A Xeljanz lawsuit claims Pfizer misled the public about the safety of the rheumatoid arthritis drug, leading to a man suffering a life-threatening blood clot.

• FDA Worried Jakafi May Have Cancer, Heart Risks Similar to Xeljanz

  June 10, 2021

  Irvin Jackson

  The FDA has delayed an expanded approval for the drug Jakafi, potentially due to concerns over heart and cancer risks linked to Pfizer's Xeljanz, a similar drug.

• Vici Venous Stent Recall Follows Reports of Stent Migration

  May 24, 2021

  Martha Garcia

  Nearly 32,000 stents use to prevent blockages in the veins are being recalled due to the risk of migration and patient injury.

• Investigation of Xeljanz Cancer and Heart Risks Launched in Canada

  April 8, 2021

  Irvin Jackson

  Growing concerns have led to Health Canada announcing a Xeljanz safety review, to determine whether more warnings or actions are needed following studies suggesting the ulcerative colitis drug could increase the risk of cancer and heart attacks.

• Xeljanz Cancer Warnings Leave More Questions Than Answers

  March 24, 2021

  Irvin Jackson

  New Xeljanz research links the drug to cancer risks, but has not yet led to a warning for users as to which types of cancer they may face.

• Xeljanz Heart and Cancer Concerns May Be Impacting FDA Review of Rinvoq for Psoriatic Arthritis

  March 19, 2021

  Irvin Jackson

  The FDA may be delaying approval for the drug Rinvoq to be used as a psoriatic arthritis drug due to its close ties to Xeljanz, which has been linked to heart risk and cancer concerns.

• Pfizer Files Lawsuit Over Xeljanz Generic Application

  March 5, 2021

  Austin Kirk

  Pfizer filed a patent lawsuit over an alleged attempt to create a generic version of Xeljanz shortly after the FDA announced new concerns about the drug's safety.

• Xeljanz Problems Highlighted in Study Data May Lead to New FDA Restrictions: Report

  February 8, 2021

  Irvin Jackson

  The FDA is weighing new restrictions on Xeljanz, following clinical trial data linking the drug to an increased risk of heart problems and cancer, according to a new report.